Sorafenib Increases Overall Survival in Asian Patients With Liver …
DG News

By Cameron Johnston COPENHAGEN, Denmark — April 29, 2009 — Treatment with sorafenib was safe and effective in patients from the Asia-Pacific region with advanced hepatic cell carcinomas (HCC) compared with placebo, regardless of the presence of lung …

Minorities to Bear Brunt of Rise in US Cancer Cases
Atlanta Journal Constitution,  USA

The authors advocated more screening and implementation of prevention efforts such as vaccinating for the hepatitis B virus (linked to liver cancer) and human papilloma viruses (the main cause of cervical cancer), reducing tobacco and alcohol use and …

Vitamin K With Sorafenib Showed Anti-tumor Effects In Pancreas …
Science Daily (press release)

Although sorafenib has demonstrated success at extending survival in patients with hepatocellular carcinoma (HCC, or primary liver cancer), hand-foot syndrome is a common adverse effect that affects approximately 20 percent of patients who receive the …

Geisinger expands its cancer center, recruits two specialists
Wilkes Barre Times-Leader, PA

Dr. TS Ravikumar, a surgical oncologist, will begin clinical trials for treatment of liver cancer. The new infusion area where patients receive chemotherapy. One of the newcomers, Dr. TS Ravikumar will begin a clinical trial Thursday in the treatment …
Geisinger opens expanded cancer facility Pocono Record
all 3 news articles

Crime Scene Cleanup
San Antonio Current, tx

When San Antonio Metro Health commissioned a study of liver cancer in southwest San Antonio in 2006, the Texas Cancer Registry provided data confirming 319 cases of liver cancer in the 14 ZIP code study area near Kelly between 1995-2003, …

Teenager with rare cancer refuses to let condition get her down
Ledbury Reporter, UK

Rosie was diagnosed in February 2008 with hepatocellular fibrolamellar carcinoma, a rare type of liver cancer. "It's pretty rare," she said. "There's only about 200 cases in the world every year." Since then she has endured two liver resections, …

Biocompatibles International plc – Statement re Drug-Eluting Bead …
Trading Markets (press release), CA

These include Drug-Eluting Bead products which are used in more than 35 countries for the treatment of primary liver cancer (HCC), liver metastases from colorectal cancer, and other cancers; and Brachytherapy products (Radiation-Delivering Seeds) which …

Aveo reports positive preclinical data from liver cancer trial
Pharmaceutical Business Review

By Datamonitor staff writer It expects to release results of phase IIB with CF101 for treatment of rheumatoid arthritis … Milestone payment payable to Tekmira upon initiation of Phase I trial … Almac's truly integrated approach provides a seaml . …

Onyx, Bayer: Nexavar Flunks Late-stage Melanoma Trial
RTT News, NY

Nexavar is currently approved in more than 70 countries for the treatment of patients with liver cancer and in more than 80 countries for the treatment of patients with advanced kidney cancer. Nexavar is developed by Onyx and Bayer HealthCare …

The Grill: Gregg Favalora talks about 3-D imaging breakthroughs
Computerworld, MA

We believe that there is a lot of opportunity to help improve so-called soft-tissue cancer treatment, such as prostate, breast and liver cancer surgery. Did you know that about half of all women who get a breast lump removed have to return because it …